BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34568025)

  • 1. Comprehensive Genomic Landscape in Chinese Clear Cell Renal Cell Carcinoma Patients.
    Huang J; Cai W; Cai B; Kong W; Zhai W; Zhang J; Chen Y; Chen S; Bai Y; Huang Y; Xue W
    Front Oncol; 2021; 11():697219. PubMed ID: 34568025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
    Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
    Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma.
    Meng H; Jiang X; Cui J; Yin G; Shi B; Liu Q; Xuan H; Wang Y
    Biomed Res Int; 2020; 2020():2495157. PubMed ID: 33062672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiles of renal cell carcinoma in a small Chinese cohort.
    Tai S; Xu DD; Yu Z; Guan Y; Yin S; Xiao J; Xue S; Liang C
    Front Oncol; 2023; 13():1095775. PubMed ID: 37427096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing.
    Lin PH; Huang CY; Yu KJ; Kan HC; Liu CY; Chuang CK; Lu YC; Chang YH; Shao IH; Pang ST
    Oncol Lett; 2021 Feb; 21(2):169. PubMed ID: 33456545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma.
    Bi H; Yin J; Zhou L; Wu Y; Ge L; Lu M; Liu L; Zhang H; Zhao Y; Liu C; Ma L
    Transl Androl Urol; 2020 Dec; 9(6):2751-2763. PubMed ID: 33457247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications.
    Jing X; Qin X; Liu H; Liu H; Wang H; Qin J; Zhang Y; Cao S; Fan X
    Eur J Med Res; 2024 Feb; 29(1):107. PubMed ID: 38326910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma.
    Bihr S; Ohashi R; Moore AL; Rüschoff JH; Beisel C; Hermanns T; Mischo A; Corrò C; Beyer J; Beerenwinkel N; Moch H; Schraml P
    Neoplasia; 2019 Feb; 21(2):247-256. PubMed ID: 30660076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and Predictive Value of
    Carril-Ajuria L; Santos M; Roldán-Romero JM; Rodriguez-Antona C; de Velasco G
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients.
    Zhou F; Huang Y; Cai W; Li J; Su C; Ren S; Wu C; Zhou C
    Lung Cancer; 2021 Mar; 153():66-72. PubMed ID: 33454519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
    Hacking SM; Pavlick D; Wang Y; Carneiro BA; Mullally M; Lu S; Canepa M; Bratslavsky G; Jacob J; Necchi A; Spiess PE; Wang L; Yakirevich E; Ross J
    Oncologist; 2023 Jul; 28(7):e508-e519. PubMed ID: 36917021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
    Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
    Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients.
    Zhang J; Tang S; Zhang C; Li M; Zheng Y; Hu X; Huang M; Cheng X
    Front Oncol; 2021; 11():742833. PubMed ID: 35087742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
    Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
    Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
    Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
    Front Oncol; 2021; 11():646338. PubMed ID: 34249685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation With Clinicopathological Features.
    Hong B; Cai L; Wang J; Liu S; Zhou J; Ma K; Zhang J; Zhou B; Peng X; Zhang N; Gong K
    Clin Genitourin Cancer; 2019 Apr; 17(2):97-104.e1. PubMed ID: 30522901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
    Carlo MI; Manley B; Patil S; Woo KM; Coskey DT; Redzematovic A; Arcila M; Ladanyi M; Lee W; Chen YB; Lee CH; Feldman DR; Hakimi AA; Motzer RJ; Hsieh JJ; Voss MH
    Kidney Cancer; 2017 Jul; 1(1):49-56. PubMed ID: 30334004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.